SC 13G: ALUMIS INC.

AI Summary

SC 13G filing by ALUMIS INC..

Risk Assessment

Risk Level: low

FAQ

Key Financial Figures

• $0.0001 — s Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of

Filing Documents

• ef20032231_sc13g.htm (SC 13G) — 146KB
• 0001140361-24-032951.txt ( ) — 148KB

(a). Name of Issuer

Item 1(a). Name of Issuer Alumis Inc. (the "Issuer")

(b). Address of Issuer's Principal Executive Offices

Item 1(b). Address of Issuer's Principal Executive Offices 280 East Grand Avenue, South San Francisco, CA 94080

(a). Names of Persons Filing

Item 2(a). Names of Persons Filing This Statement is filed on behalf of the following persons (collectively, the "Reporting Persons"): i. venBio Global Strategic Fund IV, L.P. ("Fund IV"); ii. venBio Global Strategic GP IV, LLC ("General Partner IV"); iii. Robert Adelman ("Mr. Adelman"); and iv. Corey Goodman ("Mr. Goodman"). This Statement relates to Shares (as defined herein) directly beneficially owned by Fund IV. General Partner IV is the sole general partner of Fund IV. Mr. Adelman and Mr. Goodman are members of General Partner IV. Accordingly, each of General Partner IV, Mr. Adelman and Mr. Goodman may be deemed to indirectly beneficially own the Shares reported herein.

(b). Address of Principal Business Office or, if None, Residence

Item 2(b). Address of Principal Business Office or, if None, Residence The address of the principal business office of each Reporting Person is c/o venBio Partners, LLC, 1700 Owens Street, Suite 595, San Francisco, CA 94158.

(c). Citizenship

Item 2(c). Citizenship Fund IV is a Delaware limited partnership. General Partner IV is a Delaware limited liability company. Each of Mr. Adelman and Mr. Goodman is a citizen of the United States of America.

(d). Title of Class of Securities

Item 2(d). Title of Class of Securities Common Stock, $0.0001 par value per share (the "Shares")

(e). CUSIP Number

Item 2(e). CUSIP Number 022307102 Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: This Item 3 is not applicable. SCHEDULE 13G CUSIP No. 022307102 Page 7 of 11 Pages

(a). Amount Beneficially Owned

Item 4(a). Amount Beneficially Owned As of the date hereof, each of the Reporting Persons may be deemed to beneficially own 2,826,048 Shares.

(b). Percent of Class

Item 4(b). Percent of Class The percentages set forth in row 11 are based on 44,659,821 Shares expected to be outstanding immediately after the Issuer's initial public offering, which closed on July 1, 2024, as reported in the Issuer's prospectus on Form 424B4 filed with the Securities and Exchange Commission on June 28, 2024.

(c). Number of shares as to which such person has

Item 4(c). Number of shares as to which such person has: (i) sole power to vote or to direct the vote: See Line 5 of cover sheets. (ii) shared power to vote or to direct the vote: See Line 6 of cover sheets. (iii) sole power to dispose or to direct the disposition of: See Line 7 of cover sheets. (iv) shared power to dispose or to direct the disposition of: See Line 8 of cover sheets. Each Reporting Person disclaims beneficial ownership of such securities except for the Shares, if any, such Reporting Person holds of record.

Ownership of Five Percent or Less of a Class

Item 5. Ownership of Five Percent or Less of a Class This Item 5 is not applicable.

Ownership of More than Five Percent on Behalf of Another Person

Item 6. Ownership of More than Five Percent on Behalf of Another Person This Item 6 is not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person See disclosure in Item 2 hereof.

Identification and Classification of Members of the Group

Item 8. Identification and Classification of Members of the Group This Item 8 is not applicable.

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group This Item 9 is not applicable.

Certification

Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the Issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11. SCHEDULE 13G CUSIP No. 022307102 Page 8 of 11 Pages

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: July 11, 2024 VENBIO GLOBAL STRATEGIC FUND IV, L.P. By: VENBIO GLOBAL STRATEGIC GP IV, LLC General Partner By: * Title: Member By: * Title: Member VENBIO GLOBAL STRATEGIC GP IV, LLC By: * Title: Member By: * Title: Member * Corey Goodman * Robert Adelman By: /s/ David Pezeshki David Pezeshki As attorney-in-fact This Schedule 13G was executed by David Pezeshki on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which is attached as Exhibit 2. SCHEDULE 13G CUSIP No. 022307102 Page 9 of 11 Pages EXHIBIT INDEX Ex. Page No. 1 Joint Filing Agreement 10 2 Power of Attorney regarding filings under the Securities Exchange Act of 1934, as amended. 11 SCHEDULE 13G CUSIP No. 022307102 Page 10 of 11 Pages EXHIBIT 1 JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock of Alumis Inc. dated as of July 11, 2024 is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. Dated: July 11, 2024 VENBIO GLOBAL STRATEGIC FUND IV, L.P. By: VENBIO GLOBAL STRATEGIC GP IV, LLC General Partner By: * Title: Member By: * Title: Member VENBIO GLOBAL STRATEGIC GP IV, LLC By: * Title: Member By: * Title: Member * Corey Goodman * Robert Adelman By: /s/ David Pezeshki David Pezeshki As attorney-in-fact This Agreement was executed by David Pezeshki on behalf of the individual listed above pursuant to a Power of Attorney, a copy of which is attached as Exhibit 2. SCHEDULE 13G CUSIP No. 022307102 Page 11 of 11 Pages EXHIBIT 2 POWER OF ATTORNE

View Full Filing

View this SC 13G filing on SEC EDGAR